ELMD: financial statements from SEC — TradeAlmanac

ELMD

Electromed, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024
Revenue	19m	19m	17m	16m	16m	15m
Cost of revenue	4m	4m	4m	3m	4m	3m
Gross profit	15m	15m	13m	12m	13m	11m
Research and development	361,000	384,000	241,000	277,000	251,000	166,000
Selling, general and administrative	11m	11m	10m	10m	10m	9m
Operating expenses	11m	11m	11m	10m	10m	10m
Operating income	4m	4m	3m	2m	3m	2m
Pre-tax income	4m	4m	3m	2m	3m	2m
Income tax	863,000	968,000	668,000	391,000	726,000	659,000
Net income	3m	3m	2m	2m	2m	1m
Earnings per share	0.37	0.33	0.26	0.22	0.23	0.17
Earnings per share, diluted	0.35	0.32	0.25	0.21	0.22	0.16
Weighted average shares	8m	8m	8m	8m	8m	9m
Weighted average shares, diluted	9m	9m	9m	9m	9m	9m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	17m	14m	14m	15m	15m	16m	14m	16m
Receivables	28m	26m	25m

Cash flow

Metric	Sep 30, 2025	Sep 30, 2024
Operating cash flow	169,000	2m
Depreciation and amortisation	214,000	202,000
Share-based compensation	458,000	697,000
Capital expenditure	252,000	37,000
Investing cash flow	−267,000	−58,000
Share buybacks	1m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)